Article and Video CATEGORIES
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute discusses whether or not patients on targeted therapies, such as EGFR inhibitors, should stay on those therapies after their cancers begin to grow again. February 2014.
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi and welcome to Grace. Wow, I don't know why you can't get in to see your doc but I'd find a way or find another doc who can walk you...
Hi Amber, Welcome to Grace. I'm so sorry you're going through this scare. It could be a recurrence. It also is as likely to be the contrast creating a better view. ...
Hi Blaze,
As much as I hate to say it, Welcome back Blaze. It sounds like you're otherwise feeling good and enjoying life which is a wonderful place to be. ...
Waiting for my appointment with oncologist this morning. Thank you for the response. It helps. <3
It sounds like you’re thinking of this in a very appropriate way. Specifically, it sounds like the growth of the nodule is rather modest, though keep in mind that the change...